I guess as a commercial dead-end there's no reason for this...

First 102 Last

Share
Profile

Follow
mayberichoneday

42 Posts.

13

02/04/21

16:29

Post #: 52227513
Share

Originally posted by FraserJC: ↑

I have helped introduce a new modality to help treat a range of musculoskeletal issues. I know first hand how incredibly inert and inherently risk-averse the the medical profession is to new ideas and approaches. They are even more resistant to adopt treatments based on compounds that they were told were "illegal drugs" in med school, such as magic mushrooms.

There is no massive market right now for the widespread use of them to treat mental health ailments. It is the new kid on the block amongst a wide range of clinically-proven treatment options. It will take years to complete enough clinical trials. Even then, you still have to change the conventional wisdom of the profession itself. That takes time. Same with weed, and that is 10 or 20 years down the track from mushies.

Like I said, mushies are a commercial dead end for at least the next 5 to 10 years, so I'm not sure why you think this is such a windfall. Creso will spend tens of millions trying to establish this product, which must then be recovered from their absolutely miniscule GP. The maths is not good.

Expand

I guess as a commercial dead-end there's no reason for this Phase 2 clinical trial that Halucenex is running regarding psilocybin...

And yet it remains a clinical trial that commences regardless of your bearish view

CPH Price at posting: 21.0¢ Sentiment: Buy Disclosure: Held
2 Upvote

0 Great analysis

Reply